MyDx, Inc. announced a definitive agreement with BlackSwan to provide a community engagement software platform to support its new product development initiatives under the terms of MyDx360. Licensing Agreement Provides for Branding on Multiple Delivery Mechanisms. As part of the MyDx360 agreement, BlackSwan chose from one of MyDx's base chemical formulations that best alleviated pain and inflammation according to the MyDx community. From there, MyDx software enabled BlackSwan to 'boost' that formula by changing various cannabinoid and terpene parameters as well as other natural organic terpenes to come to a final formula uniquely formulated by BlackSwan. MyDx will continue to work with BlackSwan to support the development of new formulations, which will be manufactured in the form of concentrates via state licensed suppliers, and then delivered via MyDx's hardware, the ECO Smart Pen, and supplements tailored to performance athletes. Once products have been delivered via MyDx's manufacturing partnerships, the MyDx App will provide customer-engagement support to acquire and analyze user feedback. BlackSwan to Launch I+huntr Brand for High Performance Athletes. BlackSwan intends to market its unique formula under the I+huntr Brand to athletes seeking alternatives to traditional opioid pain killers, among other ailments - an area the company has significantly researched and thinks will grow into a substantial market, especially as cannabinoid and other natural plant extract therapeutic use becomes more widely accepted.